oral glp 1 pfizer does have a drug Danuglipron: An GLP-1R Agonist Competing with Peptide Pfizer discontinues oral GLP-1 receptor
Description
Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, et al
Patients provide detailed medical history, including previous GLP-1 use, current medications, weight loss history, and specific goals
doi: 10.1038/s41574-022-00683-6
I've seen it firsthand
This lack of support can be confusing when trying to understand the correct semaglutide dosage and titration schedule
